CIAM
XBIT icon

Caitong International Asset Management’s XBiotech XBIT Stock Holding History

Caitong International Asset Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
11
– – ﹤0.01% 2484
2026
Q1 		$26 Buy
+11
New +$27 ﹤0.01% 2061

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Caitong International Asset Management's XBIT Position: Q2 2026 in Review

Caitong International Asset Management held its XBiotech (XBIT) position steady in Q2 2026 at 11 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #2484.

Caitong International Asset Management first reported a position in XBIT in Q1 2026 and has held it in 2 quarters since. The position peaked at $26 in Q1 2026. 33 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Caitong International Asset Management held 11 shares of XBiotech worth $25 as of Q2 2026.
  • Caitong International Asset Management left its XBiotech share count unchanged in Q2 2026.
  • XBiotech made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2484 holding.
  • Caitong International Asset Management first reported a position in XBiotech in Q1 2026 and has held it in 2 quarters since.
  • Caitong International Asset Management's XBiotech position peaked at $26 in Q1 2026.
  • 33 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.